Wang DY - Search Results

1

Plasma prolactin and its relationship to risk factors in human breast cancer.

Kwa HG, Cleton F, de Jong-Bakker M, Bulbrook RD, Hayward JL, Wang DY. Kwa HG, et al. Among authors: wang dy. Int J Cancer. 1976 Apr 15;17(4):441-7. doi: 10.1002/ijc.2910170405. Int J Cancer. 1976. PMID: 945228

2

Abnormalities in evening plasma prolactin levels in nulliparous women with benign or malignant breast disease.

Tarquini A, di Martino L, Malloci A, Kwa HG, van der Gugten AA, Bulbrook RD, Wang DY. Tarquini A, et al. Among authors: wang dy. Int J Cancer. 1978 Dec;22(6):687-90. doi: 10.1002/ijc.2910220608. Int J Cancer. 1978. PMID: 721323

3

An abnormal early evening peak of plasma prolactin in nulliparous and obese post-menopausal women.

Kwa HG, Bulbrook RD, Cleton F, Verstraeten AA, Hayward JL, Wang DY. Kwa HG, et al. Among authors: wang dy. Int J Cancer. 1978 Dec;22(6):691-3. doi: 10.1002/ijc.2910220609. Int J Cancer. 1978. PMID: 721324

4

Plasma immunoglobulin levels in patients with breast cancer.

Wang DY, Goodwin PR, Bulbrook RD, Hayward JL. Wang DY, et al. Cancer. 1977 May;39(5):2190-3. doi: 10.1002/1097-0142(197705)39:5<2190::aid-cncr2820390536>3.0.co;2-c. Cancer. 1977. PMID: 858130

5

Relationship of blood prolactin levels and the risk of subsequent breast cancer.

Wang DY, De Stavola BL, Bulbrook RD, Allen DS, Kwa HG, Fentiman IS, Hayward JL, Millis RR. Wang DY, et al. Int J Epidemiol. 1992 Apr;21(2):214-21. doi: 10.1093/ije/21.2.214. Int J Epidemiol. 1992. PMID: 1428472

6

Relationship of mammographic parenchymal patterns with breast cancer risk factors and risk of breast cancer in a prospective study.

de Stavola BL, Gravelle IH, Wang DY, Allen DS, Bulbrook RD, Fentiman IS, Hayward JL, Chaudary MC. de Stavola BL, et al. Among authors: wang dy. Int J Epidemiol. 1990 Jun;19(2):247-54. doi: 10.1093/ije/19.2.247. Int J Epidemiol. 1990. PMID: 2376431

7

The permanent effect of reproductive events on blood prolactin levels and its relation to breast cancer risk: a population study of postmenopausal women.

Wang DY, de Stavola BL, Bulbrook RD, Allen DS, Kwa HG, Verstraeten AA, Moore JW, Fentiman IS, Hayward JL, Gravelle IH. Wang DY, et al. Eur J Cancer Clin Oncol. 1988 Jul;24(7):1225-31. doi: 10.1016/0277-5379(88)90132-0. Eur J Cancer Clin Oncol. 1988. PMID: 3416905

8

The relationship between blood prolactin levels and risk of breast cancer in premenopausal women.

Wang DY, de Stavola BL, Bulbrook RD, Allen DS, Kwa HG, Verstraeten AA, Moore JW, Fentiman IS, Chaudary M, Hayward JL, et al. Wang DY, et al. Eur J Cancer Clin Oncol. 1987 Oct;23(10):1541-8. doi: 10.1016/0277-5379(87)90098-8. Eur J Cancer Clin Oncol. 1987. PMID: 3678318

9

Serum prolactin levels in women with breast cancer and their relationship to survival.

Wang DY, Hampson S, Kwa HG, Moore JW, Bulbrook RD, Fentiman IS, Hayward JL, King RJ, Millis RR, Rubens RD, et al. Wang DY, et al. Eur J Cancer Clin Oncol. 1986 Apr;22(4):487-92. doi: 10.1016/0277-5379(86)90116-1. Eur J Cancer Clin Oncol. 1986. PMID: 3732352

10

Identification of women at high risk of breast cancer.

Bulbrook RD, Hayward JL, Wang DY, Thomas BS, Clark GM, Allen DS, Moore JW. Bulbrook RD, et al. Among authors: wang dy. Breast Cancer Res Treat. 1986;7 Suppl:S5-10. Breast Cancer Res Treat. 1986. PMID: 3742064

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,640 results

Search Page

Filters